9:00 a.m.
Welcome and Opening Remarks
David A. Ricks, Chair and Chief Executive Officer
R&D Strategy
Daniel M. Skovronsky, M.D., Ph.D. Chief Scientific and Product Officer and President, Lilly Research Laboratories
Andrew Adams, Ph.D., Group Vice President, Molecule Discovery
Impact Obesity at Scale
Kenneth Custer, Ph.D., Executive Vice President and President, Lilly Cardiometabolic Health
Ruth Gimeno, Ph.D., Group Vice President, Diabetes & Metabolic Research
Q&A Panel
Daniel M. Skovronsky, M.D., Ph.D., Andrew Adams, Ph.D., Kenneth Custer, Ph.D. and Ruth Gimeno, Ph.D.
10:30 a.m.
Break
10:45 a.m.
The Next Big Ideas
Adrienne Brown, Executive Vice President and President, Lilly Immunology
Carole Ho, Executive Vice President and President, Lilly Neuroscience
Jacob Van Naarden, Executive Vice President; President, Lilly Oncology and Head of Corporate Business Development
and Lilly Scientific Leaders
Includes two Q&A panels.
Investing for Growth
Lucas Montarce, Executive Vice President and Chief Financial Officer
Closing Panel and Q&A
David A. Ricks, Lucas Montarce and Ilya Yuffa, Executive Vice President and President, Lilly USA and Global Customer Capabilities
1:00 p.m.
